Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 2479
  • Home
  • Print this page
  • Email this page


 
   Table of Contents      
LETTER TO THE EDITOR
Year : 2016  |  Volume : 64  |  Issue : 2  |  Page : 171-172

Handheld spectral domain optical coherence tomography seems to be a must-have device for future treatment methods of hereditary maculopathies


1 Department of Ophthalmology, Erzurum Military Hospital, Erzurum, Turkey
2 Department of Ophthalmology, Girne Military Hospital, Girne, Cyprus
3 Department of Ophthalmology, Anıttepe Military Dispensary, Ankara, Turkey
4 Department of Ophthalmology, Beytepe Military Hospital, Ankara, Turkey

Date of Web Publication5-Apr-2016

Correspondence Address:
Dr. Abdullah Kaya
Department of Ophthalmology, Anıttepe Military Dispansery, Ankara
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0301-4738.179730

Rights and Permissions

How to cite this article:
Diner O, Aksoy Y, Kaya A, SevinÁ MK. Handheld spectral domain optical coherence tomography seems to be a must-have device for future treatment methods of hereditary maculopathies. Indian J Ophthalmol 2016;64:171-2

How to cite this URL:
Diner O, Aksoy Y, Kaya A, SevinÁ MK. Handheld spectral domain optical coherence tomography seems to be a must-have device for future treatment methods of hereditary maculopathies. Indian J Ophthalmol [serial online] 2016 [cited 2019 Oct 18];64:171-2. Available from: http://www.ijo.in/text.asp?2016/64/2/171/179730

Dear Sir,

We have read with great interest the article entitled “The use of handheld spectral domain optical coherence tomography in pediatric ophthalmology practice: Our experience of 975 infants and children.”[1] We thank the author for presenting their experiences with handheld spectral domain optic coherence tomography (SD-OCT). This study has showed us that SD-OCT is a revolutionary investigation for diagnosis in pediatric population. Especially, early detection of maculopathies by this device is very exciting. Hereditary maculopathies often do not give any clinical finding in the examination of children. If there could be a development in treatment of these diseases, it will be crucial to detect maculopathy early to prevent permanent photoreceptor and/or retina pigment epithelium (RPE) injuries. Hereditary maculopathies are generally genetic disorders and characterized by progressive photoreceptor and/or RPE degeneration.[2] There are promising studies about the treatment of these diseases by gene therapy. In a recent study, retinitis pigmentosa GTPase regulator gene augmentation by adeno-associated virus 2/5 vector has been shown to prevent photoreceptor degeneration.[3] However, it investigated that this therapy could only be useful when applied before degeneration of photoreceptors. Hence, if it could be possible to cure maculopathies by genetic methods, early diagnose will be very important to survive photoreceptors. Another treatment area for hereditary maculopathies is cell replacement therapy. It could be possible to transplant stem-cell-derived photoreceptor precursors to the diseased eye. There is increasing publication about this therapy.[4] If there will be possible to apply such a therapy, early diagnose, and treatment of disease will provide better outcomes and prevent amblyopia. Thus, handheld SD-OCT seems to be a must-have device for future revolutionary treatment methods in this area of ophthalmology.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
Mallipatna A, Vinekar A, Jayadev C, Dabir S, Sivakumar M, Krishnan N, et al. The use of handheld spectral domain optical coherence tomography in pediatric ophthalmology practice: Our experience of 975 infants and children. Indian J Ophthalmol 2015;63:586-93.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.
Megaw RD, Soares DC, Wright AF. RPGR: Its role in photoreceptor physiology, human disease, and future therapies. Exp Eye Res 2015;138:32-41.  Back to cited text no. 2
    
3.
Beltran WA, Cideciyan AV, Lewin AS, Iwabe S, Khanna H, Sumaroka A, et al. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa. Proc Natl Acad Sci U S A 2012;109:2132-7.  Back to cited text no. 3
    
4.
MacLaren RE, Pearson RA, MacNeil A, Douglas RH, Salt TE, Akimoto M, et al. Retinal repair by transplantation of photoreceptor precursors. Nature 2006;444:203-7.  Back to cited text no. 4
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed619    
    Printed1    
    Emailed0    
    PDF Downloaded101    
    Comments [Add]    

Recommend this journal